Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TPXIX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
KH-815
|
|||||
| Synonyms |
KH 815; KH815
Click to Show/Hide
|
|||||
| Organization |
Chengdu Kanghong Biotechnologies Co., Ltd
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
7.5 (4+3.5)
|
|||||
| Antibody Name |
hRS7
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
Exatecan+Triptolide
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1); DNA-directed RNA polymerase II subunit RPB2 (POLR2B)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
